Chemistry and immunoassay testing system reagents and supplies
Ended Awarded Last action
- Contract number
- HT941026FE015
- Awardee
-
Ortho Clinical Diagnostics K.K. UEI E35NFBSEY3X4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $13,813
Award facts
- Contract value 100% obligated
- $13,812.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Japan
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $13,812.68 firm fixed-price blanket purchase agreement call to Ortho Clinical Diagnostics K.K. on January 6, 2026, for chemistry and immunoassay testing system reagents and supplies. The contract, with a completion date of January 16, 2026, supports laboratory diagnostic operations at U.S. military medical facilities throughout Japan. This award is issued under Ortho Clinical Diagnostics K.K.'s existing $2.875 million single-award BPA with the Defense Health Agency, effective July 1, 2024, through June 30, 2029, which was established to provide VITROS testing system reagents and consumable supplies for locations including Yokota Air Base and other military medical installations across Japan. No socioeconomic set-aside designation applies to this award.
Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro diagnostics provider Ortho Clinical Diagnostics, serves as the primary supplier of laboratory diagnostic materials to the Defense Health Agency and related defense medical commands throughout the Indo-Pacific region. The company maintains an established track record spanning 2021 through 2025, supplying critical VITROS chemistry and immunoassay testing reagents to naval hospitals, air force bases, and military medical research centers in Japan. Performance occurs at facilities in Japan, with the company holding multiple active indefinite-delivery vehicles totaling approximately $7.2 million in potential value across the Defense Health Agency, Department of Navy Bureau of Medicine and Surgery, and Pacific Air Forces, all awarded on a firm fixed-price basis without set-aside designations.
Quick answers
Who was awarded contract HT941026FE015?
HT941026FE015 was awarded to Ortho Clinical Diagnostics K.K. by Defense Health Agency (Department of Defense) on January 6, 2026.
How much is contract HT941026FE015 worth?
The government has obligated $13,813 on HT941026FE015.
Is contract HT941026FE015 an order under another contract?
Yes. HT941026FE015 is a BPA call under HT941024A0007, a blanket purchase agreement.
Was contract HT941026FE015 competed?
The extent of competition for HT941026FE015 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award